((自动化翻译由路透提供，请见免责声明 ))
9月10日 - ** 券商杰富瑞将药品分销商麦克森 的预测价格从630美元下调至607美元，同时将同行卡地纳健康 的预测价格从105美元上调至110美元。
** 尽管MCK预测 (link)，但该公司重申的全年预测给了 "一定程度的信心"。
** 竞争对手Cencora 强调COVID产品的需求下降加剧了MCK的股价压力--杰富瑞（Jefferies
** 经纪公司补充说，投资者显然担心沃尔格林 的挣扎 (link)，以及即将进行的门店整合对COR未来业绩的影响 。
** 称大多数 CAH 投资者仍希望看到更持久的执行记录
** 截至上次收盘，MCK上涨了约10%，CAH上涨了约12%，而COR则上涨了约15%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.